RARE
Closed
Ultragenyx
36.26
-0.10 (-0.28%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 36.36
Day's Range: 35.51 - 36.9899
Send
sign up or login to leave a comment!
When Written:
38.43
Ultragenyx is a biopharmaceutical company that focuses on developing treatments for rare and ultra-rare genetic diseases. The company was founded in 2010 and is headquartered in Novato, California.
Ultragenyx has a diverse pipeline of therapies in various stages of development, targeting diseases such as lysosomal storage disorders, metabolic disorders, and rare genetic diseases. The company has received FDA approval for several drugs, including Crysvita, a treatment for X-linked hypophosphatemia, and Mepsevii, a treatment for mucopolysaccharidosis VII.
In addition to its own research and development efforts, Ultragenyx also partners with other companies and academic institutions to advance rare disease research. The company is committed to improving the lives of patients with rare diseases and has a strong focus on patient advocacy and engagement.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Ultragenyx has a diverse pipeline of therapies in various stages of development, targeting diseases such as lysosomal storage disorders, metabolic disorders, and rare genetic diseases. The company has received FDA approval for several drugs, including Crysvita, a treatment for X-linked hypophosphatemia, and Mepsevii, a treatment for mucopolysaccharidosis VII.
In addition to its own research and development efforts, Ultragenyx also partners with other companies and academic institutions to advance rare disease research. The company is committed to improving the lives of patients with rare diseases and has a strong focus on patient advocacy and engagement.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








